Skip to main content

status

  • Operating in maintenance mode.

International Vaccine Access Center

Featured

Tracking Measles Cases in the U.S.

Measles outbreaks have been reported in multiple states, highlighting the importance of measles vaccination and rapid detection and reporting of suspected and confirmed measles cases. 

World map showing country-level MCV2 coverage

Visualize Latest WUENIC Data on VIEW-hub

View vaccination coverage and access estimates on VIEW-hub, IVAC's open access data visualization tool, which was recently updated to reflect 2024 WUENIC data.

Photo of researchers in lab

Vaccine Safety Trials and Placebos: An Explainer

This resource contains information developed by experts to answer commonly asked questions about vaccine safety trials and the use of placebos. 

Vaccine vials

Accelerating global access to life-saving vaccines.

We apply rigorous science to build knowledge and support for the value of vaccines.

IVAC's Work

The International Vaccine Access Center accelerates equitable and sustainable access to vaccines in low- and middle-income countries by generating, synthesizing, and using evidence to inform decision making and action.

Where We Work

 IVAC works with governments and major research institutions in 38 countries. Learn more about us.

World map identifying countries where IVAC currently has projects

What We Do: Project Highlights

Vaccine Information and Epidemiology Window (VIEW-HUB)
VIEW-hub is IVAC’s publicly accessible interactive platform to visualize real-time information on vaccine use, product type, coverage levels, impact assessments, and disease burden estimates. It can be utilized to track progress and strategize ways to accelerate and optimize vaccine implementation.
READ MORE>

Vaccine Economics Research for Sustainability & Equity (VERSE)
VERSE will compute the economic benefits and return-on-investment of vaccines, create a standardized model for assessing, tracking, and targeting vaccine coverage inequity at the country level and for monetizing the economic losses due to inequity, and more.
READ MORE >

More Projects

Stay Connected

Sign up for our monthly newsletter to receive the latest updates on immunization-related science, policy, and access from the International Vaccine Access Center at the Johns Hopkins Bloomberg School of Public Health.